These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 22451909)

  • 1. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability.
    Bilican B; Serio A; Barmada SJ; Nishimura AL; Sullivan GJ; Carrasco M; Phatnani HP; Puddifoot CA; Story D; Fletcher J; Park IH; Friedman BA; Daley GQ; Wyllie DJ; Hardingham GE; Wilmut I; Finkbeiner S; Maniatis T; Shaw CE; Chandran S
    Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5803-8. PubMed ID: 22451909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy.
    Serio A; Bilican B; Barmada SJ; Ando DM; Zhao C; Siller R; Burr K; Haghi G; Story D; Nishimura AL; Carrasco MA; Phatnani HP; Shum C; Wilmut I; Maniatis T; Shaw CE; Finkbeiner S; Chandran S
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4697-702. PubMed ID: 23401527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
    Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
    Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43.
    Gendron TF; Rademakers R; Petrucelli L
    J Alzheimers Dis; 2013; 33 Suppl 1(Suppl 1):S35-45. PubMed ID: 22751173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
    Sun X; Song J; Huang H; Chen H; Qian K
    Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific vulnerability of iPSC-derived motor neurons with TDP-43 gene mutation to oxidative stress.
    Onda-Ohto A; Hasegawa-Ogawa M; Matsuno H; Shiraishi T; Bono K; Hiraki H; Kanegae Y; Iguchi Y; Okano HJ
    Mol Brain; 2023 Jul; 16(1):62. PubMed ID: 37496071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele-specific knockdown of ALS-associated mutant TDP-43 in neural stem cells derived from induced pluripotent stem cells.
    Nishimura AL; Shum C; Scotter EL; Abdelgany A; Sardone V; Wright J; Lee YB; Chen HJ; Bilican B; Carrasco M; Maniatis T; Chandran S; Rogelj B; Gallo JM; Shaw CE
    PLoS One; 2014; 9(3):e91269. PubMed ID: 24651281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TDP-43 in aging and Alzheimer's disease - a review.
    Wilson AC; Dugger BN; Dickson DW; Wang DS
    Int J Clin Exp Pathol; 2011 Jan; 4(2):147-55. PubMed ID: 21326809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats.
    Huang C; Tong J; Bi F; Zhou H; Xia XG
    J Clin Invest; 2012 Jan; 122(1):107-18. PubMed ID: 22156203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.
    Rutherford NJ; Zhang YJ; Baker M; Gass JM; Finch NA; Xu YF; Stewart H; Kelley BJ; Kuntz K; Crook RJ; Sreedharan J; Vance C; Sorenson E; Lippa C; Bigio EH; Geschwind DH; Knopman DS; Mitsumoto H; Petersen RC; Cashman NR; Hutton M; Shaw CE; Boylan KB; Boeve B; Graff-Radford NR; Wszolek ZK; Caselli RJ; Dickson DW; Mackenzie IR; Petrucelli L; Rademakers R
    PLoS Genet; 2008 Sep; 4(9):e1000193. PubMed ID: 18802454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated Expression of Transposable Elements in TDP-43
    Valdebenito-Maturana B; Rojas-Tapia MI; Carrasco M; Tapia JC
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTK2/FAK regulates UPS impairment via SQSTM1/p62 phosphorylation in TARDBP/TDP-43 proteinopathies.
    Lee S; Jeon YM; Cha SJ; Kim S; Kwon Y; Jo M; Jang YN; Lee S; Kim J; Kim SR; Lee KJ; Lee SB; Kim K; Kim HJ
    Autophagy; 2020 Aug; 16(8):1396-1412. PubMed ID: 31690171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autopsy report of a familial amyotrophic lateral sclerosis case carrying VCP Arg487His mutation with a unique TDP-43 proteinopathy.
    Matsubara T; Izumi Y; Oda M; Takahashi M; Maruyama H; Miyamoto R; Watanabe C; Tachiyama Y; Morino H; Kawakami H; Saito Y; Murayama S
    Neuropathology; 2021 Apr; 41(2):118-126. PubMed ID: 33415820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.
    Cohen TJ; Lee VM; Trojanowski JQ
    Trends Mol Med; 2011 Nov; 17(11):659-67. PubMed ID: 21783422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction.
    Gordon D; Dafinca R; Scaber J; Alegre-Abarrategui J; Farrimond L; Scott C; Biggs D; Kent L; Oliver PL; Davies B; Ansorge O; Wade-Martins R; Talbot K
    Neurobiol Dis; 2019 Jan; 121():148-162. PubMed ID: 30290270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy.
    Spiller KJ; Cheung CJ; Restrepo CR; Kwong LK; Stieber AM; Trojanowski JQ; Lee VM
    J Neurosci; 2016 Jul; 36(29):7707-17. PubMed ID: 27445147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects.
    Langellotti S; Romano V; Romano G; Klima R; Feiguin F; Cragnaz L; Romano M; Baralle FE
    Dis Model Mech; 2016 Jun; 9(6):659-69. PubMed ID: 27101846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
    Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM
    Acta Neuropathol; 2015 Nov; 130(5):661-78. PubMed ID: 26437864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.
    Melamed Z; López-Erauskin J; Baughn MW; Zhang O; Drenner K; Sun Y; Freyermuth F; McMahon MA; Beccari MS; Artates JW; Ohkubo T; Rodriguez M; Lin N; Wu D; Bennett CF; Rigo F; Da Cruz S; Ravits J; Lagier-Tourenne C; Cleveland DW
    Nat Neurosci; 2019 Feb; 22(2):180-190. PubMed ID: 30643298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy.
    Liachko NF; Guthrie CR; Kraemer BC
    J Neurosci; 2010 Dec; 30(48):16208-19. PubMed ID: 21123567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.